COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina — Stella

Recruiting

Back to Coronary Microvascular Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Center of Cardiology, Cardiology I, university hospital Mainz, Mainz, Rhineland-Palatinate

Key details

Sponsor

Johannes Gutenberg University Mainz

Collaborators

Shockwave Medical, Inc.

Enrollment target

~144 participants

Started

April 2021

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov